Funding for Aberdeen research using shark immune systems to develop drugs

Shark Sharks are one of the most ancient species on the planet

Related Stories

A team developing anti-cancer and anti-inflammatory drugs from research based on the immune systems of sharks has received a £1.5m funding boost.

The University of Aberdeen has received the financial backing to develop man-made proteins closely related to structures found in sharks.

Sharks are one of the most ancient species on the planet.

Scottish Enterprise and the Biotechnology and Biological Sciences Research Council awarded the money.

Structures called variable novel antigen receptors (VNARs) are found in the shark immune system.

'Huge potential'

The team has produced more than 10bn of these molecules, and say their drug library is the "equivalent to having access to 10,000 sharks without needing to keep a single animal in an aquarium".

Professor Andy Porter said: "We are excited and delighted with the support we have received from Scottish Enterprise and BBSRC for our research."

Prof Stephen Logan, senior vice-principal for the University of Aberdeen, said: "This is ambitious and exciting research which will help build on Aberdeen's reputation as Scotland's commercial capital for drug discovery."

Julia Brown, director of foresighting at Scottish Enterprise, added: "The technology involved has huge potential and the challenge now is to help translate this into a successful company, located in Scotland."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

BBC North East, Orkney and Shetland

Weather

Lerwick

Min. Night 6 °C

Features

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.